Kirkland & Ellis represents Hong Kong-listed MicroPort Scientific Corporation (SEHK: 00853) in its proposed US$190 million acquisition of the Cardiac Rhythm Management (CRM) business of NASDAQ-listed…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
